维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="MESA R A"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Sauna-induced Rapid Weight Loss Decreases Explosive Power in Women butnot in Men显示文摘	GUTIERREZ A MESA J L RUIZ J R	2003	Int J Sports Med2003，24，7：	1
2	Use of the functional assessment of cancer therapy-anemia in persons with myelo- proliferative neoplasm-associated myelofibrosis and anemia 显示文摘	Tefferi A Hudgerns S Mesa R	2014	Clin Ther2014，36，4：	1
3	The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘	International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M	2010	Science2010，330，6010：	1
4	Acute myocardial infarct size is related to periodontitis extent and severity显示文摘	Marfil-Alvarez R Mesa F Catena A	2014	J Dent Res2014，21，1：	1
5	Clinical and molecular features of Ewing sarcoma in a patient with triple-X syndrome显示文摘	Patino-Garcia A Lopez de Mesa R de Alava E	1999	Cancer Genet Cytogenet1999，113，2：	1
6	Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment ( IWG-MRT ) and European LeukemiaNet (ELN) consensus report 显示文摘	Tefferi A Cervantes F Mesa R	2013	Blood2013，122，8：	1
7	Phase1/-2 study of pomalidomide in myelofibrosis 显示文摘	MESA R A PARDANANI A D HUSSEIN K	2010	Am JHematol2010，85，2：	1
8	Steroids and gunshot wounds to the spine显示文摘	Heary R Vaccaro A Mesa J	1997	Neurosurg1997，14，3：	1
9	Results of the PERSIST-1 phaseHI study of pacritinib ( PAC ) versus best available therapy ( BAT ) inprimary myelofibrosis (PPV-MF), post-polycythemia versusmyelofibrosis (PPV-MF) , or post-essential thrombocythemia-myelofibrosis ( PET-MF ) 显示文摘	Mesa R Egyed M Szoke A	2015	J Clin Oncol2015，33，15：	1
10	Transformation of Lactobacillus ptantarum by electroporation with in vitro modified plasmid DNA 显示文摘	Teresa A M Carmen R M Mesas M	2004	FEMS Microbiology Letters2004，241，1：	1
11	Navigating the evolving paradigmis in the diagnosis and treatment of myeloproliferative disorders 显示文摘	MESA R A	2007	Hematology Am Soc Hematol Educ Program2007，2007，1：	1
12	Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia显示文摘	MESA R A HANSON C A RAJKUMAR S V	2000	Blood2000，96，：	1
13	A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia显示文摘	MESA R A STEENSMA D P PARDANANI A	2003	Blood2003，101，：	1
14	Clinical correlates of splenic histopathology and splenic kaotype in myclofibrosis with myeloid metaplasia显示文摘	Mesa R A 1 i C Y Schroeder G	2001	Blood2001，97，11：	1
15	Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis 显示文摘	VERSTOVSEK S KANTARJIAN H MESA R A	2010	N Engl J Med2010，363，12：	1
16	JAK2 (V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia显示文摘	MESA R A POWELL H LASHO T	2006	Leuk Res2006，30，：	1
17	Future therapies for the myeloproliferative neoplasms显示文摘	SCHERBER R MESA R A	2011	Curr Hematol Malig Rep2011，6，：	1
18	BH3 - only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL- induced apoptosis显示文摘	MOTT J L BRONK S F MESA R A	2008	Mol Cancer Ther2008，7，8：	1
19	Safety and efficacy of INCB018424,a JAK1and JAK2inhibitor,in myelofibrosis显示文摘	VERSTOVSEK S KANTARJIAN H MESA R A	2010	N Engl J Med2010，363，：	1
20	Characterization of an endogenous plasmid and development of cloning vectors and a transformation system in Brevibacterium lactofermentum显示文摘	Santamaria R Gil J A Mesas J M	1984	J Gen Microbiol1984，130，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示